HomeClinical ToolsForrest

🩸 Forrest Classification (UGI Bleed)

Classify peptic ulcer bleeding endoscopically and estimate rebleed risk (Forrest).

Clinical takeaway

High-risk stigmata (Ia–IIa) need endoscopic haemostasis + IV PPI.

Loading calculator…
Share on XLinkedInWhatsAppEmail

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

When to use

Guide endoscopic therapy and PPI strategy in ulcer bleeding.

How it works

Ia spurting / Ib oozing / IIa visible vessel (high risk); IIb clot (intermediate); IIc flat spot / III clean base (low risk).

Key points

  • High-risk stigmata (Ia–IIa) need endoscopic haemostasis + IV PPI.
  • Low-risk lesions: oral PPI, early feeding/discharge.
  • Adherent clot (IIb): consider removal and treat the lesion.

References

Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Endoscopic appearanceIa — active spurting

Forrest IaIa active spurting

  • Rebleed risk~55% rebleed without therapy — high risk
  • ManagementEndoscopic haemostasis + IV PPI.
Endoscopic appearanceIII — clean ulcer base

Forrest IIIIII clean base

  • Rebleed risk~5% — low risk
  • ManagementNo endoscopic therapy; oral PPI, early feeding/discharge.

Frequently asked questions

What is Forrest Classification (UGI Bleed)?
Classify peptic ulcer bleeding endoscopically and estimate rebleed risk (Forrest).
How is Forrest Classification (UGI Bleed) calculated? What is the core formula?
Ia spurting / Ib oozing / IIa visible vessel (high risk); IIb clot (intermediate); IIc flat spot / III clean base (low risk).
When is Forrest Classification (UGI Bleed) used?
Guide endoscopic therapy and PPI strategy in ulcer bleeding.
What are the key clinical points for Forrest Classification (UGI Bleed)?
High-risk stigmata (Ia–IIa) need endoscopic haemostasis + IV PPI. Low-risk lesions: oral PPI, early feeding/discharge. Adherent clot (IIb): consider removal and treat the lesion.
What are the limits and cautions when using Forrest Classification (UGI Bleed)?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is Forrest Classification (UGI Bleed) calculated in practice? Can you show a worked example?
Inputs: Endoscopic appearance Ia — active spurting → Result: Forrest Ia Ia active spurting(Rebleed risk: ~55% rebleed without therapy — high risk, Management: Endoscopic haemostasis + IV PPI.) Inputs: Endoscopic appearance III — clean ulcer base → Result: Forrest III III clean base(Rebleed risk: ~5% — low risk, Management: No endoscopic therapy; oral PPI, early feeding/discharge.)

Other tools

🩸 GBS🩸 Rockall🫃 Ranson🫃 BISAP

中文版 →